China’s Ping An Insurance Company led a $15 Million investment in Riverain Technologies, an Ohio company that develops AI imaging software. Riverain’s suite of patented ClearRead(TM) software tools are designed to improve a clinician’s ability to detect cancer and other cell anomalies in thoracic CT and X-ray images. The software, which is already available in the US, is especially aimed at early detection of lung cancer. The investment will be used to bring ClearRead(TM) to global markets. Ping An’s Global Voyager Fund made the investment. Source: China Biotoday
